Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer

MLA

Christian A. Lerchenmuller, et al. “Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 33, no. 32, Aug. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8d34e8afae96e066c744f5ea0ec804f9&authtype=sso&custid=ns315887.

APA

Christian A. Lerchenmuller, Tobias Heintges, Martina Stauch, Salah-Eddin Al-Batran, Christoph Kahl, Thomas Decker, Dominik Paul Modest, Volker Heinemann, Ursula Vehling-Kaiser, Ludwig Fischer von Weikersthal, Werner Scheithauer, Svantje Held, Frank Kullmann, G. Seipelt, Sebastian Stintzing, Thomas Kirchner, Alexander Kiani, Markus Möhler, & Andreas Jung. (2015). Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(32).

Chicago

Christian A. Lerchenmuller, Tobias Heintges, Martina Stauch, Salah-Eddin Al-Batran, Christoph Kahl, Thomas Decker, Dominik Paul Modest, et al. 2015. “Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33 (32). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8d34e8afae96e066c744f5ea0ec804f9&authtype=sso&custid=ns315887.